Immunoadjuvant action of plasmid DNA in liposomes

被引:45
作者
Gürsel, M [1 ]
Tunca, S [1 ]
Özkan, M [1 ]
Özcengiz, G [1 ]
Alaeddinoglu, G [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey
关键词
immunological adjuvants; DNA vaccine; liposomes;
D O I
10.1016/S0264-410X(98)00383-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial DNA and oligodeoxynucleotides containing immunostimulatory sequences with a CpG motif stimulated a Th1 type response in vivo. The adjuvant action of a non-coding plasmid DNA derived from pRc/CMV HBS (encoding the S region of hepatitis B surface antigen, HBsAg) in mice was investigated. The role of methylation on the adjuvanticity of the plasmid as well as the effect of vaccine formulation employed on the outcome of antigen-specific humoral and cellular responses were also studied. The results demonstrated that plasmid DNA acted as a Th1 promoting adjuvant when mixed as such or co-entrapped in liposomes with a very low dose of antigen. However. the adjuvant activity was lost when separate liposome entrapped formulations of both the antigen and the plasmid DNA were mixed, indicating a necessity for the antigen and the plasmid DNA to contact the same APC for optimal immune activation. A decreased adjuvanticity of plasmid DNA upon methylation with HpaII methyltransferase was also demonstrated. A mechanism that may help partially explain the reduction in adjuvanticity after modification of C residues is also discussed. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1376 / 1383
页数:8
相关论文
共 36 条
[1]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[2]   2 DNA METHYLTRANSFERASES FROM MURINE ERYTHROLEUKEMIA-CELLS - PURIFICATION, SEQUENCE SPECIFICITY, AND MODE OF INTERACTION WITH DNA [J].
BESTOR, TH ;
INGRAM, VM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5559-5563
[3]  
BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
[4]   Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination [J].
Carson, DA ;
Raz, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1621-1622
[5]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[6]   DNA-BASED IMMUNIZATION INDUCES CONTINUOUS SECRETION OF HEPATITIS-B SURFACE-ANTIGEN AND HIGH-LEVELS OF CIRCULATING ANTIBODY [J].
DAVIS, HL ;
MICHEL, ML ;
WHALEN, RG .
HUMAN MOLECULAR GENETICS, 1993, 2 (11) :1847-1851
[7]   A NOVEL ADJUVANT FOR USE WITH A BLOOD-STAGE MALARIA VACCINE [J].
DESOUZA, JB ;
PLAYFAIR, JHL .
VACCINE, 1995, 13 (14) :1316-1319
[8]   Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): Composition, structure and immunogenicity [J].
Diminsky, D ;
Schirmbeck, R ;
Reimann, J ;
Barenholz, Y .
VACCINE, 1997, 15 (6-7) :637-647
[9]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648
[10]   THE REMOVAL OF HEPATITIS-B VIRUS FROM FACTOR-VIII CONCENTRATES BY FRACTIONATION ON ETHYLENE MALEIC-ANHYDRIDE POLY-ELECTROLYTE [J].
GALPIN, SA ;
KARAYIANNIS, P ;
MIDDLETON, SM ;
THOMAS, HC .
JOURNAL OF MEDICAL VIROLOGY, 1984, 14 (03) :229-233